Efficacy and Safety of MG in the Patients With Alcoholic Fatty Liver Disease and Alcoholic Hepatitis

Exclusion Criteria

• •Patients who have liver disease with the cause different with the alcohol except
• •Patients who have pyridoxine allergy or history
• •Patients who are judged by investigator that participation of the study is difficult due to disease as follow; hepatic cirrhosis, Wilson's disease, malignant tumor, serious metabolic disease, severe renal disease, severe pulmonary disease, severe cardiovascular disease, severe nervous disease/psychiatric disorder, muscle disease and etc
• •Patients taking other investigational product within 90 days prior to the participation in the study.
• •Patients who has been taken any medications that could affect the treatment : hypoglycemic agents, colchicine, penicillamine, corticosteroids, ursodeoxycholic acid, pentoxifylline, lont-term use of NSAIDs, statins, neuroleptics, anti convulsive medications, high-dose acetaminophen(\>=2.5g/day)
• •Patients who have received treatment that may affect liver function within 1 month prior to the participation in the study
• •Patient who considered ineligible for participation in the study as Investigator's judgment